Recurrent angioedema associated with efalizumab

Acta Dermato-Venereologica

Volumn 89, Issue 6, 2009, Pages 665-666

  Mallbris, Lotus ^a   Von Bergen, Fredrik ^b   Van Hage, Marianne ^a   Ståhle, Mona ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EFALIZUMAB;

ADULT; ANGIONEUROTIC EDEMA; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; HUMAN; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; PSORIASIS VULGARIS; RECURRENT DISEASE;

ANGIOEDEMA; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; HUMANS; MALE; MIDDLE AGED; PSORIASIS; RECURRENCE;

EID: 71949094664     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0715     Document Type: Letter

References (7)

1. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008; 58: 826-1580
2. Sterry W, Bagot M, Ferrandiz C, Kragballe K, Papp K, Stingl G. Immunosuppressive therapy in dermatology and PML. J Dtsch Dermatol Ges 2009; 7: 5.
3. Scheinfeld N. Efalizumab: a review of events reported during clinical trials and side effects. Expert Opin Drug Saf 2006; 5: 197-209. (Pubitemid 43379619)
4. Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 2005; 210: 194-199. (Pubitemid 40529233)
5. Nakamura S, Nagao A, Kishino M, Konishi H, Shiratori K. Education and imaging, gastrointestinal: angioedema of the small bowel. J Gastroenterol Hepatol 2008; 23: 1158.
6. Nopp A, Johansson SG, Ankerst J, Bylin G, Cardell LO, Gronneberg R, et al. Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation. Allergy 2006; 61: 298-302. (Pubitemid 43381805)
7. Nopp A, Johansson SG, Ankerst J, Palmqvist M, Oman H. CD-sens and clinical changes during withdrawal of Xolair after 6 years of treatment. Allergy 2007; 62: 1175-1181. (Pubitemid 47374025)